Lives and livelihoods depend on understanding Long-COVID
The RECOVER study is designed to help us understand why some people continue to feel sick after having COVID-19 and others don’t. It will also help identify what can be done to speed recovery and even prevent it. Today, doctors don’t know.
Lives and livelihoods depend on understanding Long-COVID
The RECOVER study is designed to help us understand why some people continue to feel sick after having COVID-19 and others don’t. It will also help identify what can be done to speed recovery and even prevent it. Today, doctors don’t know.
Learning faster, together
RECOVER is a national research initiative from the National Institutes of Health (NIH). The federal government recognizes the impact of COVID and has asked for an official set of rules to be created to evaluate the long-term symptoms people are reporting.
Illinois is one of 30 study centers nationwide that will develop best practices for people with difficulty recovering from COVID.
Long-COVID is real
Long-COVID is a condition that occurs after getting COVID-19. About 10-30% of people who get COVID-19 do not fully recover. Some people experience symptoms that persist for weeks or months and may come and go. For others, some symptoms go away, and new ones appear.
Progress takes all of us
The RECOVER study in Illinois is for adults who:
Currently
have COVID
Likely
had COVID
Previously
had COVID
Have not
had COVID
Meet the ILLInet RECOVER team
Dr. Jonathan D. Klein
Study Chair
University of Illinois at Chicago
Dr. Jerry A Krishnan
Lead Principal Investigator
University of Illinois at Chicago
Community partners
ILLInet is a network that includes health systems and community-based organizations in Illinois. Together, our goal is to enroll a diverse group of 1,200 people into the RECOVER study.
Community partners
ILLInet is a network that includes health systems and community-based organizations in Illinois. Together, our goal is to enroll a diverse group of 1,200 people into the RECOVER study.
Upcoming RECOVER Events
There are no upcoming events at this time
“I’ve been doing medical research for over 25 years. The RECOVER study is big! This is new, ambitious, and necessary because Long COVID is a problem.”
Previous COVID studies
Efficacy and Safety of Sarilumab for Hospitalized Patients with COVID-19
March – Sep 2020
This study determined if a study drug called sarilumab could decrease the amount of time a person has COVID-19 symptoms.
Predictors of Severe COVID-19 Outcomes (PRESCO)
May – Aug 2020
This study sought to understand the process of developing acute respiratory distress syndrome (ARDS: a condition in which fluid collects in the lungs’ air sacs, depriving organs of oxygen) in patients with COVID-19. Understanding this process helped prioritize patients with a high risk of progression to ARDS or death for earlier and more aggressive intervention.
ACTIV-4c: COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis
2021 – present
ACTIV-4c is a study to learn more about preventing blood clots in COVID-19 patients, which appears to be higher than for patients who do not have COVID-19. The purpose of this study is to compare people who take a low-dose blood thinner after leaving the hospital with people who do not.
¿Quiere seguir conectado?
ILLInet no está inscribiendo actualmente participantes en RECOVER. Sin embargo, otros estudios de COVID prolongado dirigidos por nuestros investigadores ILLInet están en marcha, incluidos los ensayos de tratamiento.
Manténgase al día sobre el estudio RECOVER y los anuncios de inscripción en COVID prolongado, eventos, noticias y estudios relacionados al COVID prolongados.